However, higher GCG expression is associated with decreased survival in breast cancer, cervical squamous cell carcinoma, esophageal adenocarcinoma, head-neck squamous cell carcinoma, ovarian cancer, stomach adenocarcinoma, and uterine corpus endometrial carcinoma. This evidence concerns the gene GCG and uterine corpus endometrial carcinoma.